Icomb 5 Mg/5 Mg Capsule Rigide

Ramipril, the active ingredient in Icomb 5 Mg/5 Mg Capsule Rigide, is an ACE inhibitor presented as a 5 mg/5 mg capsule for oral use. It reduces high blood pressure and is indicated for adult patients with hypertension, often in combination with a calcium‑channel blocker.

GNH USA supplies Icomb 5 Mg/5 Mg Capsule Rigide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other healthcare providers worldwide.

Icomb, containing ramipril and amlodipine, is used to manage conditions within the hypertension disease family.

- Hypertension: lowers systolic and diastolic blood pressure, reducing cardiovascular risk. - Essential hypertension: provides effective blood‑pressure control when monotherapy is insufficient. - Cardiovascular risk reduction in hypertensive patients: helps prevent stroke and myocardial infarction by maintaining target blood pressure.

Icomb may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Cough - Dizziness - Headache - Peripheral edema - Flushing - Fatigue

Serious or Rare Side Effects: - Angioedema - Severe hypotension - Hepatic dysfunction - Myocardial infarction - Pancreatitis - Anaphylaxis

When prescribing Icomb, several precautions should be observed to ensure patient safety.

- Monitor blood pressure: check regularly after initiation and dose changes. - Assess renal function: evaluate creatinine and eGFR before and during therapy. - Avoid in pregnancy: ACE inhibitors are contraindicated due to fetal risk. - Caution with potassium‑sparing diuretics: risk of hyperkalemia. - Counsel on orthostatic hypotension: advise patients to rise slowly. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Icomb can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Aliskiren in diabetic patients: combined use may increase risk of renal impairment and hyperkalemia. - Potassium‑supplement or potassium‑sparing diuretics: may cause dangerous hyperkalemia. - Strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin): can raise amlodipine levels leading to hypotension.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: additive blood‑pressure lowering effect, monitor for hypotension. - Lithium: ACE inhibitors may increase lithium concentrations, requiring level monitoring.